The Texas children's medication algorithm project: Report of the Texas consensus conference panel on medication treatment of childhood attention- deficit/hyperactivity disorder. Part II: Tactics

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 39, Issue 7, 2000, Pages 920-927

  Pliszka, Steven R ^a   Greenhill, Lawrence L ^b   Lynn Crismon, M ^b   Sedillo, Andrew ^b   Carlson, Caryn ^b   Keith Conners, C ^b   McCracken, James T ^b   Swanson, James M ^b   Hughes, Carroll W ^b   Llana, Maria E ^b   Lopez, Molly ^b   Toprac, Marcia G ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

Algorithm; Attention deficit hyperactivity disorder; Practice parameters; Psychopharmacology

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CLARITHROMYCIN; CLONIDINE; DEXAMPHETAMINE; ERYTHROMYCIN; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; METHYLPHENIDATE; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; PEMOLINE; PIMOZIDE; PSYCHOSTIMULANT AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

ANXIETY NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC TEST; DOSE CALCULATION; DOSE RESPONSE; DRUG CHOICE; DRUG COMPETITION; DRUG INDICATION; DRUG INDUCED DISEASE; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL SOCIETY; OBSESSION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TIC;

EID: 12944332081     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200007000-00022     Document Type: Article

References (28)

1. Ambrosini PJ, Wagner KD, Biederman J et al. (1999), Multicenter open-label sertraline study in adolescent outpatients with major depression. J Am Acad Child Adolesc Psychiatry 38:566-572
2. Barrett J, Meehan O, Fahy T (1996), SSRI and sympathomimetic interaction (letter). Br J Psychiatry 168:253
3. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A (1989), A double-blind placebo controlled study of desipramine in the treatment ADD, II: serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28:903-911
4. Birmaher B, Waterman GS, Ryan N et al. (1994), Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:993-999
5. Conners CK (1997), Conners' Rating Scales-Revised. Toronto: Multi-Health Systems
6. Conners CK, Casat CD, Gualtieri CT et al. (1996), Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35:1314-1321
7. Daly JM, Wilens T (1998), The use of tricyclic antidepressants in children and adolescents. Pediatr Clin North Am 45:1123-1135
8. Emslie GJ, Rush AJ, Weinberg WA et al. (1997), A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037
9. Fairbanks JM, Pine DS, Tancer NK et al. (1997), Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol 7:17-29
10. Findling RL, Schulz SC, Reed MD, Blumer JL (1998), The antipsychotics: a pediatric perspective. Pediatr Clin North Am 45:1205-1232
11. Gaub M, Carlson CL (1997), Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population. J Abnorm Child Psychol 25:103-111
12. Geller B, Fetner HH (1989), Children's 24-hour serum lithium level after a single dose predicts initial dose and steady-state plasma level (letter). J Clin Psychopharmacol 9:155
13. Gutgesell H, Atkins D, Barst R et al. (1999), AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatry 38:1047-1050
14. Guy AB (1991), Clinical Global Impressions Rating Scale (DHHS Publication ADM 91-B8). In: ECDEU Assessment Manual for Psychopharmacology, Revised. Washington, DC: US Government Printing Office, pp 217-222
15. Hughes CL, Emslie GJ, Crismon ML et al. (1999), The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 38:1442-1454
16. Isojarvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllyla W (1993), Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329:1383-1388
17. Keller MB, Ryan ND, Birmaher B et al. (1998), Paroxetine and imipramine in the treatment of adolescent depression. Annual Meeting of the American Psychiatric Association, Toronto. New Research Program Abstracts, No. 123
18. Kumra S, Herion D, Jacobsen LK, Briguglia C, Grothe D (1997), Case study: risperidone-induced hepatotoxicity in pediatric patients. J Am Acad Child Adolesc Psychiatry 36:701-705
19. March JS, Biederman J, Wolkow R et al. (1998), Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 280:1752-1756
20. MTA Cooperative Group (1999), A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder: The MTA Cooperative Group. Multimodal Treatment Study of Children With ADHD. Arch Gen Psychiatry 56:1073-1086
21. Pelham WE, Swanson JM, Furman MB, Schwindt H (1995), Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. J Am Acad Child Adolesc Psychiatry 34:1504-1513
22. Pelham WEJ, Wheeler T, Chronis A (1998), Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 27:190-205
23. Pliszka SR, Greenhill LL, Crismon ML et al. (2000), The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder, part I. J Am Acad Child Adolesc Psychiatry 39:908-919
24. Rapport MD, Denney C (1997), Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: is body mass predictive of clinical response? J Am Acad Child Adolesc Psychiatry 36:523-530
25. Swanson JM (1992), School-Based Assessments and Intervention for ADD Students. Irvine, CA: KC Publishing
26. Swanson JM, Kinsbourne M, Roberts W, Zucker K (1978), Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 61:21-29
27. Swanson JM, Sandman CA, Deutsch C, Baren M (1983), Methylphenidate hydrochloride given with or before breakfast, I: behavioral, cognitive, and electrophysiologic effects. Pediatrics 72:49-55
28. Weller EB, Weller RA, Fristad MA (1986), Lithium dosage guide for prepubertal children: a preliminary report. J Am Acad Child Psychiatry 25:92-95